Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.3599
0.00 (0.00%)
At close: Jun 25, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $651.49 thousand as of June 26, 2026. Its market cap has decreased by -84.24% in one year.
Market Cap
651.49K
Enterprise Value
2.44M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.36
Market Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 651.49K, a decrease of -93.24%. That is a compound annual growth rate of -91.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 651.49K | -74.10% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avenue Therapeutics | 1.01M |
| Burzynski Research Institute | 801.84K |
| SQZ Biotechnologies Company | 707.79K |
| Emmaus Life Sciences | 701.88K |
| Altamira Therapeutics | 685.86K |
| Halberd | 672.57K |
| Windtree Therapeutics | 661.32K |
| Regenerative Medical Technology Group | 593.88K |